Not available
Quote | Progenics Pharmaceuticals Inc. (NASDAQ:PGNX)
Last: | $4.10 |
---|---|
Change Percent: | -9.39% |
Open: | $4.6 |
Close: | $4.10 |
High: | $4.79 |
Low: | $3.94 |
Volume: | 34,341,608 |
Last Trade Date Time: | 06/19/2020 04:55:36 pm |
News | Progenics Pharmaceuticals Inc. (NASDAQ:PGNX)
Summary Today, we put the spotlight on Lantheus Holdings for the first time. The stock has been a big winner in 2022 thanks to the impressive growth racked up by recently launched imaging agent Pylarify. Can the good times continue for shareholders? An investment analysis foll...
Clovis, a "trading stock," has some shakiness in its fundamentals. Moreover, the shares tend to rise and fall for you to trade for short-term gains. Due to upcoming catalysts in June, Clovis is a trading stock that is about to embark on another bullish cycle. Despite being a tradi...
Message Board Posts | Progenics Pharmaceuticals Inc. (NASDAQ:PGNX)
Subject | By | Source | When |
---|---|---|---|
Why should I try to catch a falling | vinmantoo | investorshub | 02/27/2020 3:58:15 AM |
Dow is down 1k points now. Buy the | MegaDeath | investorshub | 02/24/2020 7:17:11 PM |
I sold off my remaining $PGNX shares today. | vinmantoo | investorshub | 02/24/2020 7:14:44 PM |
Good luck, I pulled the plug on $PGNX. | MegaDeath | investorshub | 02/21/2020 5:00:06 PM |
Actually, the buyout price will be lower since | vinmantoo | investorshub | 02/21/2020 4:58:41 PM |
News, Short Squeeze, Breakout and More Instantly...
Progenics Pharmaceuticals Inc. Company Name:
PGNX Stock Symbol:
NASDAQ Market:
Progenics Pharmaceuticals Inc. Website:
The second half of the year could provide some solid wins for investors in the cancer therapeutics market. In recent years, Wall Street has flocked to many of these biotechnology companies because of their potential to deliver cutting-edge treatments and generate long-term returns. As cancer ...
Biopharma Dynavax Technologies (NASDAQ: DVAX) is one of many companies racing to develop a COVID-19 vaccine. Like many coronavirus-focused companies, Dynavax has seen its shares rise on the ongoing concern related to the pandemic -- in its case, by 50% year to date. While investors may co...
Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. (“LMI”), a global leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products, today announced that it...